Sclerosis |
|
|
Clinical Trial: Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients with Systemic Sclerosis
This study is currently recruiting patients.
|
Purpose
OBJECTIVES: I. Determine whether defects in fibrillin-1 cellular processing are present in the tsk1 mouse model that carries a known FBN1 gene rearrangement and in a population of Choctaw Native American patients with systemic sclerosis who have a strong genetic predisposition to the disease. II. Determine the ultrastructural features of fibrillin-1 in these patients. III. Screen the FBN1 gene for mutations beginning at the regions homologous to the tsk1 duplication and latent transforming growth factor binding proteins in these patients and in an unaffected Choctaw control group. IV. Determine the correlation between fibrillin-1 abnormalities and clinical presentation, autoantibodies, and ethnicity.
| Condition |
|---|
| Systemic Sclerosis |
MedlinePlus related topics: Scleroderma
Study Type: Observational
Study Design: Screening
Expected Total Enrollment: 80
Study start: July 1998
PROTOCOL OUTLINE: Patients undergo punch skin biopsy obtained from the upper arm or back. Studies of fibrillin-1 synthesis and cellular processing, and FBN1 mutational analysis, linkage analysis, and genetic mapping are performed on the tissue samples. Patients from all major US ethnic groups (Caucasian, Hispanic, African Americans) will be recruited for the study in the next 2 years.
Eligibility
Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
Diagnosis of systemic sclerosis in accordance with the American College of Rheumatology preliminary criteria
Positive for systemic sclerosis antibodies (e.g., anticentromere, antitopo, antifibrillarin, or antiRNA polymerase)
Location and Contact Information
Texas
University of Texas- Houston Medical School, Houston, Texas, 77030, United States; Recruiting
Filemon Tan, M.D., Study Chair, University of Texas
More Information
Record last reviewed: December 2003
Last Updated: October 13, 2004
Record first received: October 4, 2000
ClinicalTrials.gov Identifier: NCT00006393
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


